Literature DB >> 16896701

Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injections.

Barbara Elmståhl1, Ulf Nyman, Peter Leander, Chun-Ming Chai, Klaes Golman, Jonas Björk, Torsten Almén.   

Abstract

A study was undertaken of the role of osmotoxicity in gadolinium (Gd) and iodine contrast media (CM) nephrotoxicity in ischemic porcine kidneys. Test solutions: mannitol iso-osmotic to 0.5 M: gadopentetate (1.96 Osm/kg H2O), 0.5 M: gadodiamide (0.78 Osm/kg H2O) and 0.5 M: iohexol (190 mg I/ml, 0.42 Osm/kg H2O). Each solution was injected [3 ml/kg body weight (BW)] into the balloon-occluded (10 min) renal artery of eight left-sided nephrectomized pigs. The plasma half-life of a glomerular filtration rate (GFR) marker was used to compare their effects on GFR 1-3 h post-injection. The median half-lives of the GFR marker after injection of gadopentetate (1,730 min) and mannitol 1.96 Osm/kg H2O (2,782 min) did not differ statistically (P = 0.28), but were significantly longer than after all other solutions (P < 0.001). There was no significant difference (P = 0.06) between gadodiamide (218 min) and mannitol 0.82 Osm/kg H2O (169 min), while there was (P = 0.03) between iohexol (181 min) and mannitol 0.43 Osm/kg H2O (148 min). The difference between gadodiamide and iohexol was significant (P = 0.01). Reduction in GFR, as a marker of nephrotoxicity, induced by gadopentetate correlated with its high osmolality, while the effect of gadodiamide and iohexol may include chemotoxicity. Iohexol molecules were less nephrotoxic than the Gd-CM molecules and contain three-times the number of attenuating atoms per molecule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896701     DOI: 10.1007/s00330-006-0357-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  40 in total

1.  Gadolinium-based contrast agents in angiography and interventional radiology.

Authors:  D J Spinosa; A H Matsumoto; K D Hagspiel; J F Angle; G D Hartwell
Journal:  AJR Am J Roentgenol       Date:  1999-11       Impact factor: 3.959

2.  Renal function following nephroangiography with diatrizoate. Effects of saline, mannitol, and diatrizoate on renal blood flow, glomerular permeability and filtration rate and diuresis in dogs.

Authors:  C Törnquist; T Almén; K Golman; S Holtås
Journal:  Acta Radiol Diagn (Stockh)       Date:  1984

3.  Renal renin and hemodynamic responses to selective renal artery catheterization and angiography.

Authors:  R W Katzberg; T W Morris; F A Burgener; D E Kamm; H W Fischer
Journal:  Invest Radiol       Date:  1977 Sep-Oct       Impact factor: 6.016

4.  Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.

Authors:  Marc C Heinrich; Martin K Kuhlmann; Aleksandar Grgic; Martina Heckmann; Bernhard Kramann; Michael Uder
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

5.  Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: preliminary results in 37 patients with contraindications to iodinated contrast agents.

Authors:  Martine Remy-Jardin; Philippe Dequiedt; Olivier Ertzbischoff; Isabelle Tillie-Leblond; John Bruzzi; Alain Duhamel; Jacques Remy
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

6.  Effect of four non-ionic contrast media on red blood cells in vitro. III. Deformability.

Authors:  P Aspelin; P E Nilsson; H Schmid-Schönbein; S Schröder; R Simon
Journal:  Acta Radiol Suppl       Date:  1987

Review 7.  Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?

Authors:  Ulf Nyman; Barbara Elmståhl; Peter Leander; Mats Nilsson; Klaes Golman; Torsten Almén
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

Review 8.  Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

Authors:  S K Morcos; H S Thomsen; J A Webb
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

Review 9.  Contrast nephrotoxicity.

Authors:  B J Barrett
Journal:  J Am Soc Nephrol       Date:  1994-08       Impact factor: 10.121

10.  Selective nephroangiography in the dog causing renal platelet aggregation and irregular nephrographic phase.

Authors:  T Almén; S E Bergentz; C Törnquist; B Oystese
Journal:  Acta Radiol Diagn (Stockh)       Date:  1985 Sep-Oct
View more
  10 in total

Review 1.  Recent hot topics in contrast media.

Authors:  Henrik S Thomsen
Journal:  Eur Radiol       Date:  2010-12-07       Impact factor: 5.315

2.  Ventilation/Perfusion Relationships and Gas Exchange: Measurement Approaches.

Authors:  Susan R Hopkins
Journal:  Compr Physiol       Date:  2020-07-08       Impact factor: 9.090

Review 3.  Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?

Authors:  Georg Bongartz
Journal:  MAGMA       Date:  2007-04-14       Impact factor: 2.310

Review 4.  Lung perfusion measured using magnetic resonance imaging: New tools for physiological insights into the pulmonary circulation.

Authors:  Susan R Hopkins; G Kim Prisk
Journal:  J Magn Reson Imaging       Date:  2010-12       Impact factor: 4.813

5.  A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents.

Authors:  Huanhuan Zheng; Guolang Wang; Qianqian Cao; Wenkai Ren; Lingyuan Xu; Shuangshan Bu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

6.  Synthesis, Characterization, In Vitro Phantom Imaging, and Cytotoxicity of A Novel Graphene-Based Multimodal Magnetic Resonance Imaging - X-Ray Computed Tomography Contrast Agent.

Authors:  Gaurav Lalwani; Joe Livingston Sundararaj; Kenneth Schaefer; Terry Button; Balaji Sitharaman
Journal:  J Mater Chem B       Date:  2014-06-14       Impact factor: 6.331

7.  Assessment of Gadobutrol Safety in Combination with Ionizing Radiation Using a Preclinical MRI-Guided Radiotherapy Model.

Authors:  Michael S Petronek; Emily J Steinbach; Amanda L Kalen; Zachariah J Builta; Cameron M Callaghan; Dan E Hyer; Douglas R Spitz; Ryan T Flynn; John M Buatti; Vincent A Magnotta; Diana Zepeda-Orozco; Joël J St-Aubin; Bryan G Allen
Journal:  Radiat Res       Date:  2021-03-01       Impact factor: 2.841

Review 8.  Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.

Authors:  Moshe Rogosnitzky; Stacy Branch
Journal:  Biometals       Date:  2016-04-06       Impact factor: 2.949

9.  Evaluation of Physicochemical Properties, Pharmacokinetics, Biodistribution, Toxicity, and Contrast-Enhanced Cancer MRI of a Cancer-Targeting Contrast Agent, MT218.

Authors:  Yajuan Li; Songqi Gao; Hongfa Jiang; Nadia Ayat; Victoria Laney; Calin Nicolescu; Wenyu Sun; Michael F Tweedle; Zheng-Rong Lu
Journal:  Invest Radiol       Date:  2022-05-05       Impact factor: 10.065

10.  Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injury.

Authors:  Ebru Gok Oguz; Ahmet Kiykim; Kenan Turgutalp; Refik Olmaz; Onur Ozhan; Necati Muslu; Mehmet Horoz; Simge Bardak; Mehmet Ali Sungur
Journal:  Med Sci Monit       Date:  2013-11-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.